Prevalence of movement disorders in adolescent patients with schizophrenia and in relationship to predominantly atypical antipsychotic treatment.

European Child & Adolescent Psychiatry
Stefan GebhardtHelmut Remschmidt

Abstract

To examine prevalence of movement disorders (MDs) such as tardive dyskinesia (TD), parkinsonism or akathisia in an adolescent population with schizophrenia and in relationship to predominantly atypical antipsychotic treatment. Ninety-three patients (aged 19.6+/-2.2 years) were ascertained in this cross-sectional/retrospective study. 76 patients (81.7%) received atypical, 10 (10.8%) typical antipsychotics and 7 (7.5%) combinations of atypical/typical antipsychotics. MD symptoms were assessed using Tardive Dyskinesia Rating Scale (TDRS), Abnormal Involuntary Movement Scale (AIMS), Extrapyramidal Symptom Scale (EPS), Barnes Akathisia Scale (BAS). Movement disorder symptoms were found in 37 patients (39.8%) fulfilling strict/subthreshold criteria for TD (5.4/11.8%), parkinsonism (2.2/25.8%) or akathisia (1.1/11.8%), respectively. Patients treated with typical antipsychotics displayed a significantly higher EPS-score (P=0.036) and a tendency towards a higher BAS-score (P=0.061) compared to patients with atypical antipsychotics. Treatment durations with typical/atypical antipsychotics showed trends towards advantages of atypical antipsychotics with regard to parkinsonism/akathisia symptoms (P=0.061; P=0.054), but not with regard to T...Continue Reading

References

Mar 1, 1978·Psychopharmacology·B G WinsbergA Klutch
Aug 8, 1979·Psychopharmacology·G M SimpsonG Gardos
Jan 1, 1978·Journal of the American Academy of Child Psychiatry·M CampbellE J Sachar
Oct 1, 1975·Clinical Pediatrics·G W PaulsonG E Crane
Jan 1, 1992·Schizophrenia Bulletin·R Yassa, D V Jeste
Apr 1, 1991·The British Journal of Psychiatry : the Journal of Mental Science·J A LiebermanJ Kane
May 1, 1991·Journal of the American Academy of Child and Adolescent Psychiatry·J S WerryL Chard
May 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·T R Barnes
Feb 1, 1989·Psychological Medicine·T Turner
Apr 1, 1986·Archives of General Psychiatry·C T GualtieriD Quade
Apr 1, 1988·Acta Psychiatrica Scandinavica·J Gerlach, D E Casey
Dec 1, 1988·The Australian and New Zealand Journal of Psychiatry·P Sachdev
Sep 1, 1985·European Journal of Cancer & Clinical Oncology·M DowsettS L Jeffcoate
Jul 1, 1973·Journal of Autism and Childhood Schizophrenia·P PolizosJ Waizer
Jan 1, 1970·Acta Psychiatrica Scandinavica. Supplementum·G M Simpson, J W Angus
Jan 1, 1972·Journal of Autism and Childhood Schizophrenia·J B McAndrewD A Treffert
Apr 1, 1982·Archives of General Psychiatry·J M Kane, J M Smith
Apr 1, 1982·Archives of General Psychiatry·N R Schooler, J M Kane
Jan 1, 1983·Clinical Neuropharmacology·M CampbellW G Bennett
Jun 1, 1994·The American Journal of Psychiatry·S R Marder, R C Meibach
Oct 1, 1994·Journal of Child Psychology and Psychiatry, and Allied Disciplines·P CawthronV Seagroatt
Aug 1, 1994·Archives of General Psychiatry·W S FentonT H McGlashan
Jan 1, 1994·Journal of the American Academy of Child and Adolescent Psychiatry·T MozesA Weizman
Jan 1, 1993·Schizophrenia Bulletin·M Krausz, T Müller-Thomsen
Jan 1, 1993·The Journal of Neuropsychiatry and Clinical Neurosciences·R A SweetG S Zubenko
Sep 1, 1995·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·P R Latimer
Jan 1, 1996·Psychopharmacology·D S FennD E Casey
Jun 1, 1996·The British Journal of Psychiatry : the Journal of Mental Science·O YuenR A Dickson
Jun 1, 1996·Acta Psychiatrica Scandinavica·P SachdevC Doutney
Feb 1, 1996·The British Journal of Psychiatry : the Journal of Mental Science·R G McCreadieM S Menon
Sep 1, 1995·International Clinical Psychopharmacology·D E Casey
Jun 1, 1997·Journal of the American Academy of Child and Adolescent Psychiatry·M CampbellJ E Overall
Oct 1, 1996·Journal of Child and Adolescent Psychopharmacology·S Fisman, M Steele
Jan 1, 1996·Journal of Child and Adolescent Psychopharmacology·S J GrcevichS C Schulz
Sep 19, 1997·Archives of General Psychiatry·B Vitiello, P S Jensen
Sep 20, 1997·Acta Psychiatrica Scandinavica·J van OsR Murray
Jun 1, 1997·The British Journal of Psychiatry : the Journal of Mental Science·M TuretzA Weizman
Feb 25, 1998·Journal of the American Academy of Child and Adolescent Psychiatry·S KumraJ L Rapoport
Apr 29, 1998·Journal of the American Academy of Child and Adolescent Psychiatry·R NicolsonL Sloman
Apr 29, 1998·Journal of the American Academy of Child and Adolescent Psychiatry·S KumraJ L Rapoport
Jun 25, 1998·Journal of Child and Adolescent Psychopharmacology·H A Schreier
Jul 31, 1998·Progress in Neuro-psychopharmacology & Biological Psychiatry·G W DalackJ H Meador-Woodruff
Sep 8, 1998·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·S A McDermidE D'Alessandro

❮ Previous
Next ❯

Citations

Mar 24, 2012·The British Journal of Psychiatry : the Journal of Mental Science·Michael J PelusoPeter B Jones
Mar 22, 2008·La Presse médicale·Emmanuelle DeniauDavid Cohen
Jan 6, 2015·Psychiatry and Clinical Neurosciences·Paul P LernerVladimir Lerner
May 12, 2016·International Clinical Psychopharmacology·Georgios SchoretsanitisMichael Paulzen
Feb 1, 2017·Journal of Clinical Psychopharmacology·Thierry Q MentzelUNKNOWN Genetic Risk and Outcome of Psychosis (GROUP) Investigators
Jan 5, 2017·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Eiji KoseHiroyuki Hayashi
Sep 28, 2017·International Journal of Psychiatry in Clinical Practice·Nimisha DesaiEla Vatsala
Jan 31, 2019·Progress in Rehabilitation Medicine·Yoko TsujiFumio Hirao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here